At a glance
- Originator Roche
- Class Antihyperglycaemics; Insulin sensitisers; Naphthalenes; Thiazolidinediones
- Mechanism of Action Peroxisome proliferator-activated receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Diabetes mellitus
Most Recent Events
- 11 Oct 2006 Discontinued - Preclinical for Diabetes mellitus in Germany (PO)
- 26 Feb 2001 Profile reviewed but no significant changes made
- 04 Aug 1998 No-Development-Reported for Diabetes mellitus in Germany (PO)